129 related articles for article (PubMed ID: 579034)
41. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
42. [HLA B8 and Graves' disease (author's transl)].
Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
[TBL] [Abstract][Full Text] [Related]
43. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
44. TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.
Schernthaner G; Ludwig H; Schleusener H; Finke R; Kotulla P; Mayr WR
Experientia; 1979 Oct; 35(10):1408-9. PubMed ID: 227717
[TBL] [Abstract][Full Text] [Related]
45. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
46. HL-A antigens in Graves' disease and Hashimoto's thyroiditis.
Farid NR; Barnard J; Kutas C; Noel EP; Marshall WH
Int Arch Allergy Appl Immunol; 1975; 49(6):837-42. PubMed ID: 1242384
[TBL] [Abstract][Full Text] [Related]
47. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
48. Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci.
Inoue D; Sato K; Sugawa H; Akamizu T; Maeda M; Inoko H; Tsuji K; Mori T
J Clin Endocrinol Metab; 1993 Sep; 77(3):606-10. PubMed ID: 8103768
[TBL] [Abstract][Full Text] [Related]
49. Histocompatibility antigens in Graves' disease.
Ford D; Knight JG; Reeve JK; Stewart RD
Aust N Z J Med; 1976 Aug; 6(4):297-9. PubMed ID: 1070984
[TBL] [Abstract][Full Text] [Related]
50. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
[TBL] [Abstract][Full Text] [Related]
51. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
[TBL] [Abstract][Full Text] [Related]
52. Tumor necrosis factor beta gene polymorphisms in Graves' disease.
Badenhoop K; Schwarz G; Schleusener H; Weetman AP; Recks S; Peters H; Bottazzo GF; Usadel KH
J Clin Endocrinol Metab; 1992 Feb; 74(2):287-91. PubMed ID: 1346144
[TBL] [Abstract][Full Text] [Related]
53. New HLA DRB1 and DQB1 haplotypes in a pedigree of familial Graves' disease in Japan.
Sasaki M; Yuzawa M; Saito T; Ikoma A; Tamemoto H; Kawakami M; Ishikawa SE
Endocr J; 2007 Dec; 54(5):721-5. PubMed ID: 17785916
[TBL] [Abstract][Full Text] [Related]
54. The possible influence of HLA-A1, B8 antigens on the course of Graves' disease.
Balázs CS; Stenszky V; Kozma L; Leövey A
Biomedicine; 1978 Nov; 29(8):263-4. PubMed ID: 581746
[No Abstract] [Full Text] [Related]
55. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.
Yanagawa T; Hidaka Y; Guimaraes V; Soliman M; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jan; 80(1):41-5. PubMed ID: 7829637
[TBL] [Abstract][Full Text] [Related]
56. The operation of immunological networks in Graves' disease.
Farid NR; Newton RM; Noel EP; Barnard JM; Marshall WH
Tissue Antigens; 1978 Sep; 12(3):205-11. PubMed ID: 83018
[TBL] [Abstract][Full Text] [Related]
57. Distribution of HLA-antigens in Graves' disease and in autonomous adenoma of the thyroid [proceedings].
Weise W; Wenzel KW
Diabete Metab; 1976 Sep; 2(3):163. PubMed ID: 1036990
[No Abstract] [Full Text] [Related]
58. Simultaneous occurrence of type 1 diabetes mellitus and Graves' disease: a report of two cases and a review of the literature.
Mizokami T; Yamauchi A; Sato Y; Toyonaga M; Imoto H; Kojima H; Saji H; Nunoi K
Intern Med; 2013; 52(22):2537-43. PubMed ID: 24240794
[TBL] [Abstract][Full Text] [Related]
59. A C/T polymorphism in the 5'-untranslated region of the CD40 gene is associated with Graves' disease in Koreans.
Kim TY; Park YJ; Hwang JK; Song JY; Park KS; Cho BY; Park DJ
Thyroid; 2003 Oct; 13(10):919-25. PubMed ID: 14611700
[TBL] [Abstract][Full Text] [Related]
60. [HL-A system and Graves' disease. Predominance of the DRW3 antigen].
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
Rev Med Interne; 1980; 1(2):163-70. PubMed ID: 6894803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
